Hinshaw William 4
4 · Axcella Health Inc. · Filed Oct 19, 2022
Insider Transaction Report
Form 4
Hinshaw William
DirectorPresident and CEO
Transactions
- Award
Common Stock
2022-10-17+50,000→ 98,012 total - Sale
Common Stock
2022-10-19$1.56/sh−16,000$25,027→ 82,012 total
Footnotes (3)
- [F1]On September 29, 2020, the Reporting Person was granted 50,000 restricted stock units ("RSUs"), which vest upon satisfaction of certain performance criteria. On October 17, 2022, the Issuer's Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such RSUs.
- [F2]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.52 to $1.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.